GERN
Geron Corporation · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -1.2% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | +1 | 281.21M | $360.08M | +7 | −8 |
| Q1 2026 | 93 | -3 | 271.64M | $404.62M | +7 | −10 |
| Q4 2025 | 95 | -3 | 246.07M | $324.82M | — | −3 |
| Q3 2025 | 17 | 0 | 193.54M | $265.15M | +2 | −2 |
| Q2 2025 | 14 | +1 | 162.89M | $229.67M | +1 | — |
| Q1 2025 | 10 | -1 | 76.28M | $121.30M | — | −1 |
| Q4 2024 | 11 | +1 | 96.17M | $340.44M | +2 | −1 |
| Q3 2024 | 9 | 0 | 71.98M | $326.79M | +2 | −2 |
| Q2 2024 | 9 | — | 67.08M | $284.41M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 46.61M | -6.8% | $63.85M | 0.0% | ▼ Trim | 2 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (passiv) | 34.42M | -3.3% | $47.16M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passiv) | 26.62M | +12.6% | $36.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Goldman Sachs Group ✦ | 21.31M | — | $29.19M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 5 | Citadel Advisors ✦ | 15.71M | +30.5% | $21.52M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (passiv) | 13.12M | -7.3% | $17.98M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 11.37M | +88.0% | $15.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 10.70M | — | $14.66M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 9 | Fidelity (FMR) ✦ | 7.70M | +59.2% | $10.55M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 10 | Renaissance Technologies ✦ | 2.36M | -52.7% | $3.24M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 1.85M | Neu | $2.54M | 0.0% | New | 1 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 974.50K | — | $1.34M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 13 | AQR Capital Management ✦ | 417.90K | +100.9% | $572,517 | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 14 | T. Rowe Price ✦ | 288.84K | -42.0% | $396,000 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 38.83K | +1.8% | $53,197 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 27.21K | Neu | $37,276 | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 22.53K | -97.6% | $30,869 | 0.0% | ▼ Trim | 5 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Two Sigma Investments | $2.54M | 0.0% |
| Fisher Asset Management | $37,276 | 0.0% |
Ausgestiegen
| Point72 Asset Management | $13.54M | war 0.0% |
| Wellington Management | $351,780 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 253 Inhaber, 492.17M Anteile, $730.64M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.